Autologous stem cell transplantation provides additional cytoreduction following induction therapy in multiple myeloma.

被引：0
|
作者：
Kumar, Shaji [1 ]
Lacy, Martha [1 ]
Dispenzieri, Angela [1 ]
Hayman, Suzanne [1 ]
Vincent Rajkumar, S. [1 ]
Zeldenrust, Steven [1 ]
Lust, John A. [1 ]
Greipp, Philip R. [1 ]
Kyle, Robert [1 ]
Gertz, Morie [1 ]
机构：
[1] Mayo Clin, Rochester, MN USA
来源：
BLOOD | 2006年 / 108卷 / 11期
关键词：
D O I：
10.1182/blood.V108.11.3099.3099
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3099
引用
收藏
页码：883A / 883A
页数：1
相关论文
共 50 条
  • [31] Induction therapy prior to autologous stem cell transplantation (ASCT) in newly diagnosed multiple myeloma: an update
    Abdul Hamid Bazarbachi
    Rama Al Hamed
    Florent Malard
    Ali Bazarbachi
    Jean-Luc Harousseau
    Mohamad Mohty
    Blood Cancer Journal, 12
  • [32] Long-term outcome of autologous and myeloablative allogeneic stem cell transplantation for Multiple Myeloma.
    Kuruvilla, J
    Nevill, TJ
    Nitta, J
    Le, A
    Forrest, DL
    Lavoie, JC
    Nantel, SH
    Song, KW
    Sutherland, HJ
    Toze, CL
    Hogge, DE
    Shepherd, JD
    BLOOD, 2003, 102 (11) : 475A - 475A
  • [33] Individualized high dose busulfan in patients undergoing autologous stem cell transplantation for multiple myeloma.
    Clopés, A
    Sureda, A
    Brunet, S
    Altés, A
    Martino, R
    Paladio, N
    Queraltó, JM
    Mangues, MA
    Sierra, J
    BLOOD, 2001, 98 (11) : 201A - 201A
  • [34] Feasibility of high dose busulfan and melphalan with autologous hematopoietic stem cell transplantation in multiple myeloma.
    Begum, U
    Fitzgerald, D
    Yong, LO
    Grand, M
    Thomas, U
    Chen, Y
    Patel, A
    Goodman, D
    Dillon, C
    Amorosi, E
    Cook, P
    BLOOD, 1997, 90 (10) : 4346 - 4346
  • [35] Megatherapy and autologous stem cell transplantation in patients with multiple myeloma. The experience of a single haematological clinic
    Papanicolaou, X.
    Maltezas, D.
    Dima, J.
    Dadakaridou, M.
    Hatziantoniou, V.
    Vlamis, C.
    Patos, P.
    Athanasopoulos, A.
    Repousis, P.
    Kotsopoulou, M.
    Megalakaki, A.
    Mitsouli-Mentzikoff, C.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 (06): : 191 - 191
  • [36] Double autologous stem cell transplantation with CD34 selected cells for multiple myeloma.
    Nedellec, G
    Ceccaldi, B
    Fagot, T
    Souleau, B
    Traulle, C
    Merrer, J
    De Revel, T
    Joussemet, M
    BONE MARROW TRANSPLANTATION, 1999, 23 : S137 - S137
  • [37] Predictors of blood transfusion requirements in patients undergoing autologous stem cell transplantation for multiple myeloma.
    Pendergrast, Jacob
    Al Farsi, Khalil
    Al-Huneini, Mohammed
    Maliakkal, Maya
    Pond, Gregory
    Chen, Christine
    BLOOD, 2006, 108 (11) : 848A - 848A
  • [38] Primary therapy with thalidomide and dexamethasone in preparation to autologous transplantation for multiple myeloma.
    Cavo, M
    Zamagni, E
    Tosi, P
    Cellini, C
    de Vivo, A
    Cangini, D
    Tonelli, M
    Testoni, N
    Grafone, T
    Tacchetti, P
    Soverini, S
    Terragna, C
    Tura, S
    Baccarani, M
    BLOOD, 2003, 102 (11) : 448A - 448A
  • [39] Double autologous transplantation with PBPC for multiple myeloma.
    Cavo, M
    Benni, M
    Lemoli, RM
    Ronconi, S
    Zamagni, E
    Terragna, C
    Leopardi, G
    Martinelli, G
    Gozzetti, A
    Motta, MR
    Rizzi, S
    Tura, S
    BONE MARROW TRANSPLANTATION, 1998, 21 : S212 - S212
  • [40] An immunophenotypical pattern characteristic of MGUS is achieved following autologous stem cell transplant in multiple myeloma.
    Almeida, JJ
    Mateo, GG
    Orfao, AA
    Garcia-Marcos, MAMA
    del Canizo, CC
    Moro, MJMJ
    Hernandez, JJ
    Blade, JJ
    San Miguel, JFJF
    BLOOD, 2000, 96 (11) : 421A - 421A
12345